5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → HCID 22240216, 화합물
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5](B2OC(C)(C)C(C)(C)O2)=[CH:4][C:3]=1[F:17].Cl[C:19]1[CH:20]=[C:21]([CH2:25][N:26]2[CH:30]=[CH:29][N:28]=[C:27]2[CH3:31])[N:22]=[N:23][CH:24]=1>>[ClH:1].[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:19]2[CH:20]=[C:21]([CH2:25][N:26]3[CH:30]=[CH:29][N:28]=[C:27]3[CH3:31])[N:22]=[N:23][CH:24]=2)=[CH:4][C:3]=1[F:17]참가 물질
3
실험 절차
The title compound, MS: m/e=303.3 (M+H+), was prepared from 2-(4-chloro-3-fluoro-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.
출처 및 근거
- ORD 기록
- ord-40adaec09a8749178f8a76cab54649fe
- 출처 데이터셋
- uspto-grants-2006_02
- 특허 번호
- US07005432B2
반응 노트
불러오는 중…